New drug regulations seek to protect innovation
Recent amendments to Canada's drug approval regulations, specifically to the Patented medicines Notice of Compliance (N.O.C./Linkage) Regulations have generated a lot of comments from the generic industry and their political allies.
SPONSORED CONTENT
Get Today’s Headlines Newsletter
Your quick scan of the news you need each weekday to be the smartest person in the room.
By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy
